José L Nabut

Learn More
BACKGROUND Residual renal function (RRF) impacts outcome of peritoneal dialysis (PD) patients. Some PD fluids contain glucose degradation products (GDPs) which have been shown to affect cell systems and tissues. They may also act as precursors of advanced glycosylation endproducts (AGEs) both locally and systemically, potentially inflicting damage to the(More)
OBJECTIVE To study the effect of training methods on selected patient outcomes in peritoneal dialysis patients. DESIGN Multi-center, longitudinal prospective quasi-experimental design study conducted over a 2-year period. SETTING Thirty-two Gambro Healthcare peritoneal dialysis (PD) home training programs in the United States. SUBJECTS New patients(More)
OBJECTIVES The AVOID-HF (Aquapheresis versus Intravenous Diuretics and Hospitalization for Heart Failure) trial tested the hypothesis that patients hospitalized for HF treated with adjustable ultrafiltration (AUF) would have a longer time to first HF event within 90 days after hospital discharge than those receiving adjustable intravenous loop diuretics(More)
BACKGROUND In patients hospitalized with acutely decompensated heart failure, unresolved signs and symptoms of fluid overload have been consistently associated with poor outcomes. Regardless of dosing and type of administration, intravenous loop diuretics have not reduced heart failure events or mortality in patients with acutely decompensated heart(More)
Actual blood flow rate delivered by a dialysis machine is often less than what is prescribed The Gambro Phoenix machine calculates the actual blood flow rate, reporting it as "compensated" blood flow rate. This study compared two methods of setting the prescribed rate, using Kt/V to determine the effectiveness of each. Results verified that patients achieve(More)
The role of routine right heart catheterizations (RHCs) in left ventricular assist device (LVAD) patients is undefined. We analyzed 105 continuous-flow LVAD recipients who underwent an RHC approximately 3 months after implant. In 38 patients, LVAD speed was ramped with the goal of optimizing hemodynamics. Our cohort consisted of 71 (68%) HeartMate II (HMII)(More)
  • 1